3`UTR clone of nuclear receptor coactivator 4 (NCOA4) transcript variant 2 for miRNA target validation
3`UTR clone of nuclear receptor coactivator 4 (NCOA4) transcript variant 2 for miRNA target validation
SC215025
Origene Technologies GmbH 10 µg
3`UTR clone of nuclear receptor coactivator 4 (NCOA4) transcript variant 5 for miRNA target validation
3`UTR clone of nuclear receptor coactivator 4 (NCOA4) transcript variant 5 for miRNA target validation
SC215026
Origene Technologies GmbH 10 µg
3`UTR clone of nuclear receptor coactivator 4 (NCOA4) transcript variant 4 for miRNA target validation
3`UTR clone of nuclear receptor coactivator 4 (NCOA4) transcript variant 4 for miRNA target validation
SC215027
Origene Technologies GmbH 10 µg
3`UTR clone of nuclear receptor coactivator 4 (NCOA4) transcript variant 3 for miRNA target validation
3`UTR clone of nuclear receptor coactivator 4 (NCOA4) transcript variant 3 for miRNA target validation
SC215028
Origene Technologies GmbH 10 µg
3`UTR clone of nuclear receptor coactivator 4 (NCOA4) transcript variant 1 for miRNA target validation
3`UTR clone of nuclear receptor coactivator 4 (NCOA4) transcript variant 1 for miRNA target validation
SC215207
Origene Technologies GmbH 10 µg
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6137806-01mL
MyBiosource 0.1(mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6137806-5x01mL
MyBiosource 5x0.1mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6143109-01mL
MyBiosource 0.1(mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6143109-5x01mL
MyBiosource 5x0.1mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6132503-01mL
MyBiosource 0.1(mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6132503-5x01mL
MyBiosource 5x0.1mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6148412-01mL
MyBiosource 0.1(mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6148412-5x01mL
MyBiosource 5x0.1mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6202041-01mL
MyBiosource 0.1(mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6202041-5x01mL
MyBiosource 5x0.1mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6212716-01mL
MyBiosource 0.1(mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6212716-5x01mL
MyBiosource 5x0.1mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6153715-01mL
MyBiosource 0.1(mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6153715-5x01mL
MyBiosource 5x0.1mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6159018-01mL
MyBiosource 0.1(mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6159018-5x01mL
MyBiosource 5x0.1mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6191366-01mL
MyBiosource 0.1(mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6191366-5x01mL
MyBiosource 5x0.1mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6223391-01mL
MyBiosource 0.1(mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6223391-5x01mL
MyBiosource 5x0.1mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6234066-01mL
MyBiosource 0.1(mL
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein,
MBS6234066-5x01mL
MyBiosource 5x0.1mL
Eya4 (untagged) - Rat EYA transcriptional coactivator and phosphatase 4 (Eya4)
Eya4 (untagged) - Rat EYA transcriptional coactivator and phosphatase 4 (Eya4)
RN217003
Origene Technologies GmbH 10 µg
EYA1 (untagged) - Human EYA transcriptional coactivator and phosphatase 1 (EYA1), transcript variant 6
EYA1 (untagged) - Human EYA transcriptional coactivator and phosphatase 1 (EYA1), transcript variant 6
SC336314
Origene Technologies GmbH 10 µg
EYA3 (untagged) - Human EYA transcriptional coactivator and phosphatase 3 (EYA3), transcript variant 4
EYA3 (untagged) - Human EYA transcriptional coactivator and phosphatase 3 (EYA3), transcript variant 4
SC336593
Origene Technologies GmbH 10 µg
EYA3 (untagged) - Human EYA transcriptional coactivator and phosphatase 3 (EYA3), transcript variant 3
EYA3 (untagged) - Human EYA transcriptional coactivator and phosphatase 3 (EYA3), transcript variant 3
SC336624
Origene Technologies GmbH 10 µg
EYA3 (untagged) - Human EYA transcriptional coactivator and phosphatase 3 (EYA3), transcript variant 2
EYA3 (untagged) - Human EYA transcriptional coactivator and phosphatase 3 (EYA3), transcript variant 2
SC336679
Origene Technologies GmbH 10 µg
EYA4 (untagged) - Human EYA transcriptional coactivator and phosphatase 4 (EYA4), transcript variant 5
EYA4 (untagged) - Human EYA transcriptional coactivator and phosphatase 4 (EYA4), transcript variant 5
SC336883
Origene Technologies GmbH 10 µg
EYA1 (untagged) - Human EYA transcriptional coactivator and phosphatase 1 (EYA1), transcript variant 5
EYA1 (untagged) - Human EYA transcriptional coactivator and phosphatase 1 (EYA1), transcript variant 5
SC336887
Origene Technologies GmbH 10 µg
EYA4 (untagged) - Human EYA transcriptional coactivator and phosphatase 4 (EYA4), transcript variant 6
EYA4 (untagged) - Human EYA transcriptional coactivator and phosphatase 4 (EYA4), transcript variant 6
SC337084
Origene Technologies GmbH 10 µg
Eya4 (myc-DDK-tagged) - Rat EYA transcriptional coactivator and phosphatase 4 (Eya4)
Eya4 (myc-DDK-tagged) - Rat EYA transcriptional coactivator and phosphatase 4 (Eya4)
RR217003
Origene Technologies GmbH 10 µg
Ncoa4 (untagged ORF) - Rat nuclear receptor coactivator 4 (Ncoa4), transcript variant 1, (10 ug)
Ncoa4 (untagged ORF) - Rat nuclear receptor coactivator 4 (Ncoa4), transcript variant 1, (10 ug)
RN200016
Origene Technologies GmbH 10 µg
Ncoa4 (untagged) - Rat nuclear receptor coactivator 4 (Ncoa4), transcript variant 2
Ncoa4 (untagged) - Rat nuclear receptor coactivator 4 (Ncoa4), transcript variant 2
RN217015
Origene Technologies GmbH 10 µg
EYA1 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 1 (EYA1), transcript variant 6
EYA1 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 1 (EYA1), transcript variant 6
RC238420
Origene Technologies GmbH 10 µg
EYA3 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 3 (EYA3), transcript variant 4
EYA3 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 3 (EYA3), transcript variant 4
RC238699
Origene Technologies GmbH 10 µg
EYA3 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 3 (EYA3), transcript variant 3
EYA3 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 3 (EYA3), transcript variant 3
RC238730
Origene Technologies GmbH 10 µg
EYA3 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 3 (EYA3), transcript variant 2
EYA3 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 3 (EYA3), transcript variant 2
RC238785
Origene Technologies GmbH 10 µg
EYA4 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 4 (EYA4), transcript variant 5
EYA4 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 4 (EYA4), transcript variant 5
RC238989
Origene Technologies GmbH 10 µg
EYA1 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 1 (EYA1), transcript variant 5
EYA1 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 1 (EYA1), transcript variant 5
RC238993
Origene Technologies GmbH 10 µg
EYA4 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 4 (EYA4), transcript variant 6
EYA4 (myc-DDK-tagged) - Human EYA transcriptional coactivator and phosphatase 4 (EYA4), transcript variant 6
RC239190
Origene Technologies GmbH 10 µg
NCOA3 (untagged)-Human nuclear receptor coactivator 3 (NCOA3) transcript variant 4
NCOA3 (untagged)-Human nuclear receptor coactivator 3 (NCOA3) transcript variant 4
SC329352
Origene Technologies GmbH 10 µg
NCOA3 (untagged)-Human nuclear receptor coactivator 3 (NCOA3) transcript variant 3
NCOA3 (untagged)-Human nuclear receptor coactivator 3 (NCOA3) transcript variant 3
SC329353
Origene Technologies GmbH 10 µg
NCOA3 (untagged)-Human nuclear receptor coactivator 3 (NCOA3), transcript variant 2
NCOA3 (untagged)-Human nuclear receptor coactivator 3 (NCOA3), transcript variant 2
SC316311
Origene Technologies GmbH 10 µg
NCOA4 (untagged)-Human nuclear receptor coactivator 4 (NCOA4), transcript variant 2
NCOA4 (untagged)-Human nuclear receptor coactivator 4 (NCOA4), transcript variant 2
SC326123
Origene Technologies GmbH 10 µg
NCOA4 (untagged)-Human nuclear receptor coactivator 4 (NCOA4), transcript variant 1
NCOA4 (untagged)-Human nuclear receptor coactivator 4 (NCOA4), transcript variant 1
SC326147
Origene Technologies GmbH 10 µg